Freja Ebeling

3PUBLICATIONS
38CO-AUTHORS
AutoimmunityMedical bacteriologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 17, 2024
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Magnus Tobiasson, Tatjana Pandzic, Johanna Illman

|Oct 17, 2022
Sequential high-sensitivity mutational and chimerism analyses predict responses to post-transplant salvage therapies in MDS.

Freja Ebeling, Johanna Illman, Matti Kankainen

Pageof 1